Intra Cellular Therapies Price Prediction

ITCIDelisted Stock  USD 131.87  0.03  0.02%   
As of 21st of July 2025 The value of RSI of Intra Cellular's share price is above 80 . This usually indicates that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 88

 Buy Peaked

 
Oversold
 
Overbought
The successful prediction of Intra Cellular's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Intra Cellular Therapies, which may create opportunities for some arbitrage if properly timed.
Using Intra Cellular hype-based prediction, you can estimate the value of Intra Cellular Therapies from the perspective of Intra Cellular response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Intra Cellular to buy its stock at a price that has no basis in reality. In that case, they are not buying Intra because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Intra Cellular after-hype prediction price

    
  USD 131.87  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intra Cellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
101.46101.46145.06
Details
Naive
Forecast
LowNextHigh
134.87134.87134.87
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
131.73131.84131.96
Details

Intra Cellular After-Hype Price Prediction Density Analysis

As far as predicting the price of Intra Cellular at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intra Cellular or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Intra Cellular, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Intra Cellular Estimiated After-Hype Price Volatility

In the context of predicting Intra Cellular's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intra Cellular's historical news coverage. Intra Cellular's after-hype downside and upside margins for the prediction period are 131.87 and 131.87, respectively. We have considered Intra Cellular's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
131.87
131.87
Downside
131.87
After-hype Price
131.87
Upside
Intra Cellular is very steady at this time. Analysis and calculation of next after-hype price of Intra Cellular Therapies is based on 3 months time horizon.

Intra Cellular Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Intra Cellular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intra Cellular backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intra Cellular, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
5 Events / Month
8 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
131.87
131.87
0.00 
0.00  
Notes

Intra Cellular Hype Timeline

Intra Cellular Therapies is currently traded for 131.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Intra is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Intra Cellular is about 0.0%, with the expected price after the next announcement by competition of 131.87. About 96.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.73. Intra Cellular Therapies had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Intra Cellular Related Hype Analysis

Having access to credible news sources related to Intra Cellular's direct competition is more important than ever and may enhance your ability to predict Intra Cellular's future price movements. Getting to know how Intra Cellular's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intra Cellular may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ALKSAlkermes Plc 0.45 7 per month 1.49 (0.02) 3.08 (2.83) 9.89 
IRWDIronwood Pharmaceuticals(0.20)2 per month 5.82  0.05  10.77 (9.23) 45.59 
DCPHDeciphera Pharmaceuticals LLC 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PCRXPacira BioSciences, 0.1 9 per month 0.00 (0.16) 4.49 (2.88) 12.26 
COLLCollegium Pharmaceutical 0.23 9 per month 1.43  0.06  2.72 (2.53) 8.47 
EGRXEagle Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NBIXNeurocrine Biosciences 0.29 9 per month 0.91  0.21  3.71 (1.95) 11.72 
DVAXDynavax Technologies(0.24)9 per month 0.00 (0.08) 3.10 (3.19) 15.15 
AMPHAmphastar P(1.06)11 per month 0.00 (0.18) 2.53 (3.77) 8.97 
ANIPANI Pharmaceuticals(0.49)9 per month 0.00 (0.08) 3.20 (3.06) 10.51 
CYTHCyclo Therapeutics(0.20)21 per month 5.50  0.04  10.00 (10.14) 76.39 
AMRXAmneal Pharmaceuticals, Class(0.02)10 per month 1.93  0.02  2.97 (3.22) 8.91 
AQSTAquestive Therapeutics 0.02 8 per month 4.24  0.16  8.44 (5.02) 26.24 

Intra Cellular Additional Predictive Modules

Most predictive techniques to examine Intra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intra using various technical indicators. When you analyze Intra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Intra Cellular Predictive Indicators

The successful prediction of Intra Cellular stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intra Cellular Therapies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intra Cellular based on analysis of Intra Cellular hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Intra Cellular's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intra Cellular's related companies.

Story Coverage note for Intra Cellular

The number of cover stories for Intra Cellular depends on current market conditions and Intra Cellular's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intra Cellular is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intra Cellular's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Intra Cellular Short Properties

Intra Cellular's future price predictability will typically decrease when Intra Cellular's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intra Cellular Therapies often depends not only on the future outlook of the potential Intra Cellular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intra Cellular's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding103.1 M
Cash And Short Term InvestmentsB
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Intra Stock

If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra Cellular's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stocks Directory
Find actively traded stocks across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories